Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)
China flag China · Delayed Price · Currency is CNY
5.15
-0.05 (-0.96%)
Feb 13, 2026, 3:04 PM CST

SHE:002872 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
278.48270.42192.71278.25338.68291.73
Short-Term Investments
-----40
Trading Asset Securities
----82-
Cash & Short-Term Investments
278.48270.42192.71278.25420.68331.73
Cash Growth
14.59%40.32%-30.74%-33.86%26.81%-7.71%
Accounts Receivable
117.34158.01181.16195.01240.01581.25
Other Receivables
155.38159.58170.94186.7780.8561.17
Receivables
272.73317.59352.11381.78320.87642.43
Inventory
110.44106.8136.22130.87124.58288.58
Other Current Assets
19.637.631025.1854.0848.19
Total Current Assets
681.28702.44691.04816.08920.211,311
Property, Plant & Equipment
1,4151,4641,5811,6131,6381,761
Long-Term Investments
44.5443.3950.2552.465013.53
Goodwill
-----3.64
Other Intangible Assets
277.41285.9311.77319.5327.14368.72
Long-Term Deferred Tax Assets
78.7177.5868.0764.9769.1597.81
Long-Term Deferred Charges
19.4823.416.3311.7414.5127.49
Other Long-Term Assets
132.66139.0792.4392.64101.4462.88
Total Assets
2,6492,7362,8112,9713,1203,646
Accounts Payable
42.7146.4777.3455.31126.45297.18
Accrued Expenses
6.9614.3410.2825.2714.5214.8
Short-Term Debt
103.1280.28117.3489.59132.42395.55
Current Portion of Long-Term Debt
-49.582.98143.4549.59-
Current Portion of Leases
-0.831.622.182.71-
Current Income Taxes Payable
6.440.530.463.190.51.55
Current Unearned Revenue
21.2223.3638.4246.7325.6514.61
Other Current Liabilities
157.74144.01126.12189.68120.72185.97
Total Current Liabilities
338.19359.31454.55555.39472.55909.66
Long-Term Debt
224.28234.54118.889.65219.42190.71
Long-Term Leases
1.732.454.844.39.65-
Long-Term Unearned Revenue
107.82115.42127.79126.34131.46150.97
Long-Term Deferred Tax Liabilities
3.914.074.472.842.811.09
Other Long-Term Liabilities
3.2464.84.544.93.8
Total Liabilities
679.17721.8715.25783.06840.791,256
Common Stock
318318318318318318
Additional Paid-In Capital
1,4011,4011,4011,4011,4011,401
Retained Earnings
235.38280.72368.12461.2551.76619.57
Comprehensive Income & Other
7.476.184.582.82.892.01
Total Common Equity
1,9622,0062,0912,1832,2732,340
Minority Interest
8.218.644.184.825.8149.35
Shareholders' Equity
1,9702,0142,0962,1882,2792,390
Total Liabilities & Equity
2,6492,7362,8112,9713,1203,646
Total Debt
329.14367.61325.58329.17413.78586.26
Net Cash (Debt)
-50.65-97.19-132.86-50.926.89-254.53
Net Cash Per Share
-0.16-0.31-0.42-0.160.02-0.80
Filing Date Shares Outstanding
318318318318318318
Total Common Shares Outstanding
318318318318318318
Working Capital
343.09343.12236.49260.69447.65401.27
Book Value Per Share
6.176.316.586.867.157.36
Tangible Book Value
1,6841,7201,7801,8631,9461,968
Tangible Book Value Per Share
5.305.415.605.866.126.19
Buildings
-1,6761,6631,4201,4021,176
Machinery
-535.34533.41516.98520.48506.6
Construction In Progress
-33.881.96291.84252.61655.75
Source: S&P Global Market Intelligence. Standard template. Financial Sources.